✦ LIBER ✦

PEE2: COSTS AND CONSEQUENCES OF OLOPATADINE 0.1% VERSUS LEVOCABASTINE 0.05% IN THE TREATMENT OF SEASONAL ALLERGIC CONJUNCTIVITIS

✍ Scribed by A Lafuma; F Fagnani; M Nuijten; G Berdeaux

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PEE3: COSTS AND CONSEQUENCES OF OLOPATAD

✍ A Lafuma; F Fagnani; M Nuijten; G Berdeaux 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 55 KB

Double-masked, randomized, parallel-grou

✍ Giorgio Ciprandi; Darell Turner; Robert D. Gross 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 115 KB

Emedastine ophthalmic solution 0.05% ver

✍ Peter A Netland; Charles Leahy; Kathleen L Krenzer 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 282 KB

Comparison of the efficacy of olopatadin

✍ Kamis, Umit ;Ozturk, Banu T. ;Ozkagnici, Ahmet ;Gunduz, Kemal 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 53 KB

PRS5: COST-EFFECTIVENESS OF EMEDASTINE V

✍ C Gouveia Pinto; A Lafuma; F Fagnani; G Berdeaux 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

Loteprednol Etabonate Ophthalmic Suspens

✍ Elion-Mboussa, A.; Gong, L.; Roy, L.; Zhu, B.; DeCory, H.; Chu, E. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 42 KB